CAS: 2229974-83-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | XY028-140 REF: 54-BUP00722CAS: 2229974-83-6 | 98% | 379.00 €~876.00 € | Thu 24 Apr 25 |
 | XY028-140 REF: 3D-EPD97483CAS: 2229974-83-6 | Min. 95% | To inquire | Wed 04 Jun 25 |
 | XY028-140 REF: TM-T36694CAS: 2229974-83-6 | 98.59% | 40.00 €~597.00 € | Wed 25 Jun 25 |
Ref: 54-BUP00722
| 25mg | 379.00 € | ||
| 50mg | 599.00 € | ||
| 100mg | 876.00 € |
Estimated delivery in United States, on Thursday 24 Apr 2025
XY028-140
CAS:2229974-83-6
Please enquire for more information about XY028-140 including the price, delivery time and more detailed …
Formula:
C39H40N10O7
Purity:
Min. 95%
Molecular weight:
760.8 g/mol
Ref: 3D-EPD97483
| 10mg | 725.00 € | ||
| 25mg | 1,281.00 € | ||
| 50mg | 1,782.00 € | ||
| 100mg | 2,778.00 € |
Estimated delivery in United States, on Wednesday 4 Jun 2025
XY028-140
CAS:2229974-83-6
XY028-140 is a selective CDK4/6 inhibitor and degrader, acting via PROTAC with ligands for Cereblon …
Formula:
C39H40N10O7
Purity:
98.59%
Color and Shape:
Solid
Molecular weight:
760.8
Ref: TM-T36694
| 1mg | 40.00 € | ||
| 5mg | 88.00 € | ||
| 10mg | 126.00 € | ||
| 25mg | 250.00 € | ||
| 50mg | 400.00 € | ||
| 100mg | 597.00 € |
Estimated delivery in United States, on Wednesday 25 Jun 2025
